Customize Your Own Peptide Pool!
Published on 12/12/2024
Custom PepMix™ Peptide Pools can be tailored to your exact specifications and application, offering unparalleled precision and flexibility.
Here is what we bring to the table:
Key Features:
- A variety of quality grades, backed by rigorous quality management.
- In silico design tools for optimized performance. We are here to help!
- Packaging and aliquotation in tubes, plates, PepSup™ formulations, or even your own tubes — all prepared in an ISO8 clean room environment.
- Optional Analysis such as stability testing, endotoxin and sterility testing, and many more
- Small scale (5-20 µg/peptide) and large scale (1mg/peptide or more) options
- Post-translational modifications (PTMs)
Applications:
Custom PepMix™ peptide pools are ideal for antigen-specific T-cell stimulation in T-cell assays (e.g. in ELISpot, cytokine staining, cell-mediated cytotoxicity or proliferation assays) in
- Basic Research
- Regulated Research (GLP studies)
- Clinical Development As critical raw materials
Quality Grades:
- Research Grade: Micro-scale, unpurified, fast delivery and low cost
- Development Grade: flexible scales starting from 1mg upwards, purity at 70%-90, each peptide is analyzed via HPLC
- Trial Grade: flexible scales starting from 1mg upwards, purity at 90%-95%, each peptide is analyzed via HPLC, further analyis services optional
Pool Formats:
- Overlapping peptide pools to represent an entire protein
- Selected epitope pools to combine multiple immunodominant epitopes
- Matrix pools for efficient epitope mapping
- ULTRA pools for ultimate coverage of natural sequence variants
- Individual peptide aliquots
Benefits of Custom PepMix™ Pools:
- The individual peptides are quality controlled and guaranteed for identity and purity CoA and HPLC-MS data available for each individual peptide batch
- No false positive T-cell responses due to contaminating deletion peptides
- No toxic inhibition of T-cell responses due to stringent purification of each peptide
- Minimization of endotoxin contamination due to low bioburden process
- ADCF policy